Pear Therapeutics News

Pear Therapeutics | EFFECT: Others

Jan 12, 2023 13:15

Pear Therapeutics | 424B5: Prospectus

Jan 11, 2023 05:20

Pear Therapeutics | 424B3: Prospectus

Jan 5, 2023 05:19

Pear Therapeutics | EFFECT: Others

Jan 4, 2023 13:15

Pear Therapeutics | 424B3: Prospectus

Jan 3, 2023 19:39

Pear Therapeutics | 424B3: Prospectus

Nov 15, 2022 06:21

Pear Therapeutics | 424B3: Prospectus

Aug 12, 2022 05:20

Pear Therapeutics | 424B3: Prospectus

Jul 26, 2022 04:02

Pear Therapeutics | 424B3: Prospectus

Jun 15, 2022 20:26

Pear Therapeutics | 424B3: Prospectus

Jun 15, 2022 20:04

Pear Therapeutics | 424B3: Prospectus

May 17, 2022 05:19

Pear Therapeutics | 424B3: Prospectus

May 12, 2022 22:18

Pear Therapeutics | 424B3: Prospectus

May 12, 2022 21:23

Pear Therapeutics | 424B3: Prospectus

Mar 31, 2022 04:03

Pear Therapeutics | EFFECT: Others

Mar 30, 2022 12:15

Pear Therapeutics | 424B3: Prospectus

Jan 4, 2022 05:04

Pear Therapeutics | EFFECT: Others

Jan 3, 2022 13:15

Pear Therapeutics | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

Dec 1, 2021 05:42

Pear Therapeutics | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

Nov 24, 2021 06:19

Pear Therapeutics | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

Nov 23, 2021 05:51